Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis. [PDF]
Gatti M, De Paola R, Giorgi B, Pea F.
europepmc +1 more source
Investigation of Carbapenemase Resistance Genes and Plasmid-Mediated Quinolone Resistance Genes in Ceftolozane/Tazobactam-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i> Isolates. [PDF]
Çınar C +6 more
europepmc +1 more source
<i>In vivo</i> efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant <i>Pseudomonas aeruginosa</i> carrying the AmpC E219K substitution. [PDF]
Rodríguez-Coello A +14 more
europepmc +1 more source
Long-term trends in ceftolozane-tazobactam susceptibility among gram-negative pathogens in the United States: a nine-year SMART analysis (2016-2024). [PDF]
Wise MG +6 more
europepmc +1 more source
Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study. [PDF]
Gómez de la Torre Pretell JC +5 more
europepmc +1 more source
Clinical Outcomes and Healthcare Resource Utilization of Ceftolozane/Tazobactam in Vulnerable Patient Populations. [PDF]
Yücel E +7 more
europepmc +1 more source
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study. [PDF]
Yücel E +9 more
europepmc +1 more source
Clinical Outcomes and Healthcare Resource Utilization Results Among Hospitalized Adults with Cystic Fibrosis Treated with Ceftolozane/Tazobactam: A SPECTRA Real-World Subgroup Analysis. [PDF]
Yucel E +7 more
europepmc +1 more source
Cost-effectiveness of ceftolozane/tazobactam compared to meropenem in ventilator-associated pneumonia. [PDF]
Buendía JA +2 more
europepmc +1 more source
Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial. [PDF]
Benítez-Cano A +15 more
europepmc +1 more source

